Hillman Solutions (HLMN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
27 Dec, 2025Executive summary
Q1 2025 net sales rose 2.6% year-over-year to $359.3 million, driven by the Intex DIY acquisition, new business wins, and growth in Protective and Robotics segments, partially offset by a decline in Canada.
Net loss narrowed to $(0.3) million, or $(0.00) per diluted share, compared to $(1.5) million, or $(0.01) per share, in Q1 2024, reflecting improved operating performance and lower interest costs.
Adjusted EBITDA increased to $54.5 million (15.2% margin), up from $52.3 million (14.9% margin) in Q1 2024.
Supply chain diversification advanced, with China exposure reduced to 33% and a target of 20% by year-end.
Full-year 2025 net sales and adjusted EBITDA guidance reiterated; free cash flow guidance withdrawn due to tariff uncertainties.
Financial highlights
Hardware and Protective Solutions net sales rose 5.6% to $274.4 million, with growth from the Intex acquisition and new business.
Robotics and Digital Solutions net sales increased 1.9% to $56.5 million, mainly due to price increases.
Canada segment net sales fell 18.7% to $28.4 million, impacted by lower volume and unfavorable currency exchange.
Adjusted gross margin was 46.9%, down from 47.6% a year ago, impacted by mix from recent acquisitions.
Free cash flow was negative $21.3 million, reflecting inventory build and capital investments.
Outlook and guidance
Full-year 2025 net sales guidance reiterated at $1.495–$1.575 billion (midpoint $1.535 billion, 4% growth).
Adjusted EBITDA guidance held at $255–$275 million (midpoint $265 million, 10% growth).
Free cash flow guidance withdrawn due to tariff timing uncertainties.
Targeting year-end net debt/EBITDA leverage around 2.5x.
Guidance assumes tariff-related price increases offset by volume declines, with market volumes expected down 17% in H2.
Latest events from Hillman Solutions
- Record 2025 sales and EBITDA, with 2026 guidance focused on growth and margin normalization.HLMN
Q4 202517 Feb 2026 - Q2 net income and EBITDA rose on flat sales; profit outlook up, sales guidance down.HLMN
Q2 20242 Feb 2026 - Net income and EBITDA rose in Q3 2024, with higher guidance and a $7.8M True Value charge.HLMN
Q3 202416 Jan 2026 - Record EBITDA, margin gains, and improved profitability set stage for 2025 growth.HLMN
Q4 202423 Dec 2025 - Shareholders will vote on director elections, compensation, share plans, and auditor ratification.HLMN
Proxy Filing2 Dec 2025 - Q2 sales up 6.2%, guidance raised, tariffs raise costs, $100M buyback approved.HLMN
Q2 202523 Nov 2025 - Record Q3 sales and profit growth, with raised guidance and improved leverage despite tariff headwinds.HLMN
Q3 20254 Nov 2025